Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-week Double-Blind, Parallel-Group, Placebo- and Active- Controlled Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate Inhalation Solution 20 Mcg in the Treatment of Patients With Chronic Obstructive Pulmonary Disease

NCT00215436 is registered in ClinicalTrials.gov with Dey as lead sponsor.

NCT NCT00215436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00215436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-week Double-Blind, Parallel-Group, Placebo- and Active- Controlled Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate Inhalation Solution 20 Mcg in the Treatment of Patients With Chronic Obstructive Pulmonary Disease
Lead sponsor
Dey
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2005
Completion date
September 30, 2006
Enrollment
345
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

copd